Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H5Cl2NO3 |
| Molecular Weight | 258.058 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC(O)=C2C(Cl)=CC(Cl)=CC2=N1
InChI
InChIKey=BGKFPRIGXAVYNX-UHFFFAOYSA-N
InChI=1S/C10H5Cl2NO3/c11-4-1-5(12)9-6(2-4)13-7(10(15)16)3-8(9)14/h1-3H,(H,13,14)(H,15,16)
| Molecular Formula | C10H5Cl2NO3 |
| Molecular Weight | 258.058 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands. | 2004-03 |
|
| Selective antagonism of rat inhibitory glycine receptor subunits. | 2004-02-01 |
|
| Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats. | 1998-05-18 |
|
| The role of striatal glutamate receptors in models of Parkinson's disease. | 1998 |
|
| Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice. | 1996-10 |
|
| Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. | 1994-09-01 |
|
| Yohimbine-induced seizures involve NMDA and GABAergic transmission. | 1992-04 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:52:16 GMT 2025
by
admin
on
Mon Mar 31 19:52:16 GMT 2025
|
| Record UNII |
T61ORK73PY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5,7-Dichlorokynurenic acid
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
C066192
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
DB01931
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
DTXSID80893710
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
131123-76-7
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
1779
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY | |||
|
T61ORK73PY
Created by
admin on Mon Mar 31 19:52:16 GMT 2025 , Edited by admin on Mon Mar 31 19:52:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
Binding assay
IC50
|